Path: ...!3.eu.feeder.erje.net!2.eu.feeder.erje.net!feeder.erje.net!feeder1.feed.usenet.farm!feed.usenet.farm!peer02.ams4!peer.am4.highwinds-media.com!news.highwinds-media.com!fx15.ams4.POSTED!not-for-mail
MIME-Version: 1.0
User-Agent: Mozilla Thunderbird
Subject: =?UTF-8?Q?Re=3A_Pourquoi_2_vaccins_en_m=C3=AAme_temps_=3F?=
Newsgroups: fr.bio.medecine
References: <MPG.3f9a7c4876d1c0ac98a203@news.individual.net>
 <4hQ1N.201680$ESLc.2611@fx10.ams4> <uia9ql$dk7v$1@dont-email.me>
 <la22N.788273$2Glf.620344@fx02.ams4> <uiailt$etjt$1@dont-email.me>
 <gz42N.534779$qkdf.87843@fx07.ams4> <uib8sb$ieo5$1@dont-email.me>
 <0hq2N.684695$MyOe.374736@fx03.ams4> <uidho4$11ngq$1@dont-email.me>
Content-Language: fr
From: Paul Aubrin <paul.aubrin@invalid.org>
In-Reply-To: <uidho4$11ngq$1@dont-email.me>
Content-Type: text/plain; charset=UTF-8; format=flowed
Content-Transfer-Encoding: 8bit
Lines: 13
Message-ID: <RXt2N.1007201$pyw.769790@fx15.ams4>
X-Complaints-To: abuse@eweka.nl
NNTP-Posting-Date: Tue, 07 Nov 2023 16:53:05 UTC
Organization: Eweka Internet Services
Bytes: 1797
Date: Tue, 7 Nov 2023 17:53:04 +0100
X-Received-Bytes: 1563
X-Original-Bytes: 1511

Le 07/11/2023 à 15:31, Olivier@ a écrit :
> Paul Aubrin a pensé très fort :
> 
>>   Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) 
>> Naturally Acquired Immunity versus Vaccine-induced Immunity, 
>> Reinfections versus Breakthrough Infections: A Retrospective Cohort Study
>>
>> Clinical Infectious Diseases, Volume 75, Issue 1, 1 July 2022, Pages 
>> e545–e551, https://doi.org/10.1093/cid/ciac262
> 
> Votre étude date de l'époque du variant delta. Celle *postérieure* du 
> NEJM s'intéresse au variant omicron.
Omicron, c'est aussi de l'histoire ancienne.